Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients — Stella

Home/Sarcoma/Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients

View on ClinicalTrials.gov

Recruiting

Back to Sarcoma trials

Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients

Trial locations(1 site)

United Kingdom

The Royal Marsden Hospital, London

Key details

Sponsor

Royal Marsden NHS Foundation Trust

Collaborators

Institute of Cancer Research, United Kingdom, University of Edinburgh

Enrollment target

~800 participants

Started

November 2021

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.